Table 2 Correlations between the decline in the ESMCSAs and clinical parameters.
Variables | r | 95%CI | P-value |
|---|---|---|---|
Age, year | −0.044 | −0.244–0.156 | 0.637 |
Baseline body mass index, kg/m2 | −0.175 | −0.357–0.020 | 0.057 |
Baseline FVC, % predicted | −0.285 | −0.464–−0.089 | 0.002 |
Baseline FEV1/FVC, % | 0.187 | −0.009–0.369 | 0.042 |
Baseline DLCO, % predicted | −0.172 | −0.337–0.017 | 0.063 |
Baseline distance walked during 6MWT, m | −0.171 | −0.341–0.019 | 0.064 |
Baseline lowest SpO2 during 6MWT, % | −0.290 | −0.458–−0.101 | 0.002 |
Relative decline in FVC, % | 0.202 | 0.022–0.358 | 0.028 |
Relative decline in DLCO, %* | 0.083 | −0.096–0.267 | 0.377 |
Relative decline in body mass index, % | 0.394 | 0.217–0.552 | <0.001 |